Stock Taper 
BIOIMPACT CAPITAL LLC
Latest 13F filing data - Q2 2026
Holdings
(Top positions)| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
 Dyne Therapeutics, Inc. | DYN | 1.92M | $42.69M |
 Alumis Inc. | ALMS | 2.02M | $56.82M |
 Relay Therapeutics, Inc. | RLAY | 2.42M | $45.2M |
 Trevi Therapeutics, Inc. | TRVI | 3.07M | $57.32M |
 Aktis Oncology, Inc. | AKTS | 4.84M | $155.86M |
 Cullinan Therapeutics, Inc. | CGEM | 9.73M | $177.21M |